X-Linked Hypophosphatemia

What X-linked hypophosphatemia is

XLH is the most common inherited phosphate-wasting disorder. Disease-causing variants in PHEX lead to excess activity of fibroblast growth factor 23, or FGF23. This signal reduces phosphate reabsorption by the kidneys and changes active vitamin D production, leaving less phosphate available for normal mineralization.

In growing children, poor mineralization at growth plates causes rickets. In adults, defective mineralization of mature bone is called osteomalacia. XLH can also affect teeth, joints, tendon and ligament attachments, hearing, and the shape of the skull and legs.

XLH is not the same as nutritional vitamin D deficiency, calcium deficiency, kidney failure, or tumor-induced osteomalacia. Those conditions can share laboratory or bone findings but need different evaluation and treatment.

Signs in infants and children

A child may have slow growth after beginning to walk, bowed or knock-kneed legs, widened wrists or ankles, an unusual gait, bone pain, muscle weakness, or delayed motor progress. Severity varies widely, including within a family.

Dental abscesses can develop in teeth that do not have obvious decay because dentin and enamel may be abnormal. Recurrent swelling, pain, fever, or facial infection needs prompt dental care rather than repeated home treatment.

Some children develop early fusion of skull sutures, called craniosynostosis. Persistent headache, vomiting, vision change, abnormal head growth, or developmental concern requires specialist assessment. These symptoms have many causes and do not confirm raised pressure on their own.

Routine childhood activity supports strength and participation. A child should not be restricted from all movement because of leg shape, but pain, fractures, surgery, or severe deformity may require individualized limits.

Features in adults

Adults may have persistent or recurrent bone pain, pseudofractures or stress fractures, muscle weakness, short stature, reduced walking endurance, and early osteoarthritis. Enthesopathy, which is abnormal mineralization where tendons or ligaments attach to bone, can cause stiffness and limited range of motion.

Spinal ligament mineralization or narrowing can occasionally compress nerves or the spinal cord. New weakness, numbness, loss of bladder or bowel control, saddle-area numbness, or rapidly changing walking needs urgent assessment.

Hearing loss, tinnitus, dental infection, fatigue, and psychosocial impact may also occur. Adult XLH is not merely a childhood condition that stops after growth ends, and care should not focus only on leg shape.

When urgent care is needed

Use emergency services for new spinal-cord compression signs, a serious fracture with deformity or loss of circulation, severe breathing difficulty, or acute neurologic change. Seek prompt care for a suspected fracture, inability to bear weight, spreading dental or facial infection, fever with a swollen jaw, or severe headache with neurologic or visual symptoms.

After orthopedic surgery, increasing pain, fever, wound drainage, calf swelling, chest pain, or breathlessness needs urgent review. A person receiving disease-specific medicine should follow the prescribing team’s plan for serious allergic symptoms or abnormal laboratory results.

How clinicians evaluate low phosphate

Phosphate varies with age, time of day, meals, medicines, and laboratory method. Children normally have higher levels than adults, so age-specific ranges are essential. A repeat fasting sample may be used when an unexpected low result is found.

Blood tests can include phosphate, calcium, alkaline phosphatase, creatinine, parathyroid hormone, and vitamin D measures. Paired blood and urine samples help determine whether the kidneys are inappropriately losing phosphate. FGF23 can support selected diagnostic questions but is not a stand-alone test or a routine measure of treatment response.

Clinicians assess growth, leg alignment, teeth, pain, mobility, family history, and imaging. X-rays can show rickets or osteomalacia, while other imaging is selected for fractures, spine symptoms, craniosynostosis, or surgical planning.

Genetic diagnosis and inheritance

A pathogenic PHEX variant can confirm XLH and guide family testing. A variant of uncertain significance does not establish the diagnosis by itself. Some people with a convincing clinical and biochemical pattern may need expanded testing for other phosphate-wasting conditions when PHEX testing is negative.

XLH follows an X-linked inheritance pattern, but unlike many X-linked disorders, people with one altered PHEX copy can be affected regardless of sex. An affected father passes the altered X chromosome to all daughters and no sons. A mother with one altered copy has a chance of passing it in each pregnancy.

Relatives can have mild disease and still benefit from evaluation. Early diagnosis can support dental care, growth and bone monitoring, and timely treatment. Genetic counseling can explain reproductive options without suggesting that phenotype can be predicted precisely.

Distinguishing XLH from look-alikes

Nutritional rickets usually relates to vitamin D, calcium, or dietary factors and does not follow the same renal phosphate-wasting mechanism. Other inherited kidney-tubule disorders, hereditary hypophosphatemic rickets genes, and medication effects can also lower phosphate.

Tumor-induced osteomalacia usually begins later and is caused by an FGF23-producing tumor rather than a PHEX variant. Finding a low phosphate level in an adult should not automatically lead to an XLH label or to an uncontrolled search for a tumor.

Kidney disease, malabsorption, alcohol use, refeeding, respiratory changes, and endocrine disorders can alter phosphate. Correct diagnosis matters because treatment can worsen complications if the mechanism is wrong.

Conventional treatment

Traditional treatment uses divided oral phosphate with an active vitamin D analogue. This can improve rickets and support growth and mineralization, but it does not correct the underlying FGF23 excess. Doses are adjusted from clinical response and safety monitoring rather than simply forcing serum phosphate into a normal range.

Too much phosphate or active vitamin D can contribute to high calcium in urine, kidney mineral deposits, high parathyroid hormone, gastrointestinal symptoms, or abnormal calcium levels. Kidney ultrasound and blood and urine tests may be part of monitoring.

Ordinary vitamin D supplements do not substitute for prescribed active vitamin D when the treatment plan requires it. Over-the-counter phosphate products, enemas, or supplements can be dangerous and should never be used to self-treat XLH.

FGF23-targeted treatment

Burosumab is an antibody that blocks FGF23 activity and is authorized for XLH in eligible children and adults in several regions. It can improve phosphate handling and selected bone outcomes. Eligibility, dose, timing, and access depend on age, current treatment, kidney function, pregnancy, local authorization, and specialist assessment.

Phosphate and active vitamin D products generally require specific discontinuation timing before burosumab under the prescribing plan. Combining regimens without supervision can cause excessive phosphate or calcium-related complications.

Monitoring includes fasting phosphate at defined times relative to dosing and assessment for high phosphate, kidney concerns, injection reactions, restless legs, or other adverse effects. A person should not adjust an injection schedule from a home phosphate result.

Orthopedic care and surgery

Some leg deformity improves with medical treatment during growth, while severe or persistent alignment problems may need guided-growth procedures or corrective osteotomy. Decisions consider age, growth remaining, pain, function, mechanical alignment, and metabolic control.

Surgery should be coordinated with a team familiar with metabolic bone disease. Poor mineralization, hardware stress, delayed healing, and recurrence can affect timing and technique. Surgery is not judged only by cosmetic appearance.

Adults with fractures or joint replacement needs may require metabolic optimization and rehabilitation. Physical therapy can improve strength and function but cannot straighten a fixed bony deformity by exercise alone.

Dental and hearing care

Preventive dental care is central because microscopic defects can allow infection even without obvious cavities. Regular examinations, careful hygiene, and rapid evaluation of pain, swelling, or gum drainage can reduce complications. Dental sealants or other preventive strategies are individualized.

Antibiotics may be needed for a spreading infection but do not repair the source. Repeated abscesses deserve coordination between dental and metabolic-bone teams.

Hearing symptoms should be assessed rather than assumed to be unavoidable XLH. Audiology and ear evaluation can identify treatable causes and support communication.

Pain, movement, and daily function

Pain may come from osteomalacia, fracture, enthesopathy, osteoarthritis, muscle strain, or another condition. The plan can include disease treatment, safe analgesia, physiotherapy, pacing, mobility aids, sleep support, and mental-health care.

Low-impact and strength activity can support health when adapted to pain, alignment, balance, and fracture status. Blanket exercise avoidance can worsen conditioning. A sudden focal pain or loss of function needs fracture assessment before activity is increased.

School and workplace accommodations may include rest breaks, accessible transport, adapted seating, extra time between rooms, and protection from repetitive high-impact load. The person’s own goals should guide support.

Pregnancy and life transitions

Pregnancy planning should review disease treatment, calcium and phosphate status, mobility, pelvic and spine history, pain medicine, and inheritance. Evidence for some XLH therapies during pregnancy and breastfeeding is limited, so changes require metabolic-bone and obstetric guidance.

Children transitioning to adult care need a record of PHEX results, growth and alignment, surgeries, dental history, hearing, kidney imaging, medicines, and monitoring. Treatment does not automatically stop when height growth is complete.

Preparing for specialist care

Bring age-specific laboratory results with collection times, genetic report, growth chart, radiographs, fracture and surgery history, dental infections, hearing concerns, medicines and supplements, family history, pain locations, and mobility goals.

Ask which evidence confirms renal phosphate wasting, how look-alikes were excluded, what each treatment is expected to improve, and how kidney, parathyroid, growth, bone, and dental safety will be monitored.

Common questions

Is XLH caused by not eating enough phosphorus?

No. It is usually caused by PHEX-related FGF23 excess that makes the kidneys waste phosphate. Diet alone cannot correct this mechanism.

Does one low phosphate result prove XLH?

No. Age, timing, kidney handling, medicines, nutrition, other laboratory values, family history, and genetics all matter.

Does XLH affect only children?

No. Adults can have osteomalacia, fractures, enthesopathy, arthritis, dental problems, hearing issues, pain, and mobility limitations.

Can regular vitamin D cure it?

No. Correcting ordinary vitamin D deficiency may be important, but XLH treatment targets phosphate wasting and requires specialist-selected therapy.

Should phosphate be taken without monitoring?

No. Unsupervised phosphate can cause serious calcium, parathyroid, kidney, and gastrointestinal problems and may not address the true diagnosis.